Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 10:05 PM
Study NCT ID:
NCT01186458
Status:
TERMINATED
Last Update Posted:
2016-10-24
First Post:
2010-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Sponsor:
Hoosier Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-19
First Submit QC Date:
None
Study First Post Date:
2010-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-30
Results First Submit QC Date:
None
Results First Post Date:
2016-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-30
Last Update Post Date:
2016-10-24
Last Update Post Date Type:
ESTIMATED